Literature DB >> 11883691

Prime-boost immunization strategies for infectious diseases.

Helen McShane1.   

Abstract

New vaccination strategies that induce the cellular arm of the immune response are needed for the development of effective prophylactic and therapeutic vaccines against a number of intracellular pathogens. DNA vaccines, recombinant viral vectors and recombinant proteins are all effective antigen delivery systems for inducing cellular immunity; however, when used alone, the levels of specific responses they induce are low. Prime-boost immunization strategies involve using two different vaccines, each encoding the same antigen, some weeks apart. Such strategies have been shown to enhance cellular immunity in several different animal and disease models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883691

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  16 in total

Review 1.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 2.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

3.  DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

Authors:  Anna Gil; Siyuan Shen; Scott Coley; Laura Gibson; Don J Diamond; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2013-07-25       Impact factor: 3.452

4.  Immune responses to oral vaccination with Salmonella-delivered avian pathogenic Escherichia coli antigens and protective efficacy against colibacillosis.

Authors:  John Hwa Lee; Atul A Chaudhari; In Gyoung Oh; Seong Kug Eo; Sang-Youel Park; Chetan V Jawale
Journal:  Can J Vet Res       Date:  2015-07       Impact factor: 1.310

5.  Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.

Authors:  Gloria González-Aseguinolaza; Yurie Nakaya; Alberto Molano; Edward Dy; Mariano Esteban; Dolores Rodríguez; Juan Ramón Rodríguez; Peter Palese; Adolfo García-Sastre; Ruth S Nussenzweig
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.

Authors:  Lindsay J Hall; Simon Clare; Derek Pickard; Simon O Clark; Dominic L F Kelly; Moataz Abd El Ghany; Christine Hale; Jes Dietrich; Peter Andersen; Philip D Marsh; Gordon Dougan
Journal:  Vaccine       Date:  2009-09-13       Impact factor: 3.641

7.  Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.

Authors:  M Magdalena Gherardi; José Luis Nájera; Eva Pérez-Jiménez; Susana Guerra; Adolfo García-Sastre; Mariano Esteban
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Authors:  Elena Quaglino; Simona Rolla; Manuela Iezzi; Michela Spadaro; Piero Musiani; Carla De Giovanni; Pier Luigi Lollini; Stefania Lanzardo; Guido Forni; Remo Sanges; Stefania Crispi; Pasquale De Luca; Raffaele Calogero; Federica Cavallo
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.

Authors:  Matthew G Cottingham; Andre van Maurik; Manola Zago; Angela T Newton; Richard J Anderson; M Keith Howard; Jörg Schneider; Michael A Skinner
Journal:  Clin Vaccine Immunol       Date:  2006-07

10.  Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.

Authors:  Fabio Fiorino; Elena Pettini; Gianni Pozzi; Donata Medaglini; Annalisa Ciabattini
Journal:  Front Immunol       Date:  2013-05-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.